Status:
NOT_YET_RECRUITING
Gender-Affirming Care and Mental Health
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Lund University
Conditions:
Gender Dysphoria, Adult
Psychiatric Comorbidities
Eligibility:
All Genders
18+ years
Brief Summary
Introduction Gender-Affirming Care and Mental Health (GLOW) investigates the psychological, medical, and social factors that influence the outcomes of gender-affirming care, as well as its impact on m...
Detailed Description
The GLOW study is a longitudinal investigation designed to evaluate the effects of gender-affirming care on the well-being of individuals diagnosed with gender dysphoria in Sweden. Grounded in an inte...
Eligibility Criteria
Inclusion
- Individuals aged 18 years and older.
- Referred to the National Highly Specialized Care Unit (NHV) for gender dysphoria at Region Skåne.
- Presenting for initial clinical assessment for gender-affirming care.
- Able to provide informed consent for participation in the self-report portion of the study.
- Participants may identify as female, male, or another gender identity.
Exclusion
- Inability to read or write Swedish, as all self-report measures and consent forms are in Swedish.
- Individuals with protected (secret) identities, such as those under special confidentiality protections or in high-security identity protection programs
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07171645
Start Date
January 1 2026
End Date
August 31 2032
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department/Office of Psychiatry, National specialized medical care, Skåne University Hospital, Lund, Sweden.
Lund, Skåne County, Sweden, 22185